Immunohistochemistry for histone H3 lysine 9 methyltransferase and demethylase proteins in human melanomas

American Journal of Dermatopathology

Volumn 36, Issue 3, 2014, Pages 211-216

  Miura, Shinpei ^a   Maesawa, Chihaya ^a   Shibazaki, Masahiko ^a   Yasuhira, Shinji ^a   Kasai, Syuya ^a   Tsunoda, Kanako ^a   Maeda, Fumihiko ^a   Takahashi, Kazuhiro ^a   Akasaka, Toshihide ^a   Masuda, Tomoyuki ^a  

^a IWATE MEDICAL UNIVERSITY   (Japan)

Author keywords

EHMT2; H3K9; LSD1; Melanoma; SETDB1

Indexed keywords

HISTONE H3; HISTONE H3 LYSINE 9 DEMETHYLASE; HISTONE H3 LYSINE 9 METHYLTRANSFERASE; LYSINE; LYSINE SPECIFIC DEMETHYLASE 1; METHYLTRANSFERASE; PROTEIN EHMT2; PROTEIN SETDB1; UNCLASSIFIED DRUG;

ACRAL LENTIGINOUS MELANOMA; ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER SURVIVAL; CARCINOGENESIS; DISTANT METASTASIS; FEMALE; HISTONE METHYLATION; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MALIGNANT LENTIGO; MELANOMA; MIDDLE AGED; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIMARY TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; SUPERFICIAL SPREADING MELANOMA; SURVIVAL RATE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HISTOCOMPATIBILITY ANTIGENS; HISTONE DEMETHYLASES; HISTONE-LYSINE N-METHYLTRANSFERASE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; MALE; MELANOMA; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROTEIN METHYLTRANSFERASES; SKIN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84896974218     PISSN: 01931091     EISSN: 15330311     Source Type: Journal    
DOI: 10.1097/DAD.0b013e3182964e02     Document Type: Article

References (27)

1. Ives NJ, Stowe RL, Lorigan P, et al. Chemotherapy compared with biochemotherapy for the treatment of metastatic melanoma: A metaanalysis of 18 trials involving 2,621 patients. J Clin Oncol. 2007;25: 5426-5434
2. Siegel R, DeSantis C, Virgo K, et al. Cancer treatment and survivorship statistics, 2012. CA Cancer J Clin. 2012;62:220-241
3. Goldberg AD, Allis CD, Bernstein E. Epigenetics: A landscape takes shape. Cell. 2007;128:635-638
4. Chambeyron S, Bickmore WA. Chromatin decondensation and nuclear reorganization of the HoxB locus upon induction of transcription. Genes Dev. 2004;18:1119-1130
5. Hublitz P, Albert M, Peters AH. Mechanisms of transcriptional repression by histone lysine methylation. Int J Dev Biol. 2009;53:335-354
6. Nielsen PR, Nietlispach D, Mott HR, et al. Structure of the HP1 chromodomain bound to histone H3 methylated at lysine 9. Nature. 2002; 416:103-107
7. Rea S, Eisenhaber F, O'Carroll D, et al. Regulation of chromatin structure by site-specific histone H3 methyltransferases. Nature. 2000;406: 593-599
8. Park YS, Jin MY, Kim YJ, et al. The global histone modification pattern correlates with cancer recurrence and overall survival in gastric adenocarcinoma. Ann Surg Oncol. 2008;15:1968-1976
9. Seligson DB, Horvath S, Shi T, et al. Global histone modification patterns predict risk of prostate cancer recurrence. Nature. 2005;435: 1262-1266
10. Wei Y, Xia W, Zhang Z, et al. Loss of trimethylation at lysine 27 of histone H3 is a predictor of poor outcome in breast, ovarian, and pancreatic cancers. Mol Carcinog. 2008;47:701-706
11. Ceol CJ, Houvras Y, Jane-Valbuena J, et al. The histone methyltransferase SETDB1 is recurrently amplified in melanoma and accelerates its onset. Nature. 2011;471:513-517
12. Chen MW, Hua KT, Kao HJ, et al. H3K9 histone methyltransferase G9a promotes lung cancer invasion and metastasis by silencing the cell adhesion molecule Ep-CAM. Cancer Res. 2010;70:7830-7840
13. Huang J, Dorsey J, Chuikov S, et al. G9a and Glp methylate lysine 373 in the tumor suppressor p53. J Biol Chem. 2010;285:9636-9641
14. Metzger E, Wissmann M, Yin N, et al. LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcription. Nature. 2005;437:436-439
15. Scoumanne A, Chen X. The lysine-specific demethylase 1 is required for cell proliferation in both p53-dependent and-independent manners. J Biol Chem. 2007;282:15471-15475
16. Aagaard L, Laible G, Selenko P, et al. Functional mammalian homologues of the Drosophila PEV-modifier Su(var)3-9 encode centromereassociated proteins which complex with the heterochromatin component M31. EMBO J. 1999;18:1923-1938
17. Tachibana M, Sugimoto K, Nozaki M, et al. G9a histone methyltransferase plays a dominant role in euchromatic histone H3 lysine 9 methylation and is essential for early embryogenesis. Genes Dev. 2002;16: 1779-1791
18. Shi Y, Lan F, Matson C, et al. Histone demethylation mediated by the nuclear amine oxidase homolog LSD1. Cell. 2004;119:941-953
19. Balch CM, Gershenwald JE, Soong SJ, et al. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol. 2009;27:6199-6206
20. Ishihara K, Saida T, Otsuka F, et al. Statistical profiles of malignant melanoma and other skin cancers in Japan: 2007 update. Int J Clin Oncol. 2008;13:33-41
21. Lee HY, Chay WY, Tang MB, et al. Melanoma: Differences between Asian and Caucasian patients. Ann Acad Med Singapore. 2012;41:17-20
22. Akasaka K, Maesawa C, Shibazaki M, et al. Loss of class III beta-Tubulin induced by histone deacetylation is associated with chemosensitivity to paclitaxel in malignant melanoma cells. J Invest Dermatol. 2009;129: 1516-1526
23. Saldanha G, Potter L, DaForno P, et al. Cutaneous melanoma subtypes show different BRAF and NRAS mutation frequencies. Clin Cancer Res. 2006;12:4499-4505
24. Dong C, Wu Y, Yao J, et al. G9a interacts with Snail and is critical for Snail-mediated E-cadherin repression in human breast cancer. J Clin Invest. 2012;122:1469-1486
25. Massoumi R, Kuphal S, Hellerbrand C, et al. Down-regulation of CYLD expression by Snail promotes tumor progression in malignant melanoma. J Exp Med. 2009;206:221-232
26. Jaeger J, Koczan D, Thiesen HJ, et al. Gene expression signatures for tumor progression, tumor subtype, and tumor thickness in laser-microdissected melanoma tissues. Clin Cancer Res. 2007;13:806-815
27. Macgregor S, Montgomery GW, Liu JZ, et al. Genome-wide association study identifies a new melanoma susceptibility locus at 1q21.3. Nat Genet. 2011;43:1114-1118.